Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2002
12/12/2002US20020187537 Culture product; polypeptide
12/12/2002US20020187535 Enzymatic polypeptide for use in the treatment of emphysema, adult respiratory distress syndrome and psoriasis
12/12/2002US20020187531 Process for recovering statin compounds from a fermentation broth
12/12/2002US20020187530 Biological systems for manufacture of polyhydroxyalkanoate polymers containing 4-hydroxyacids
12/12/2002US20020187527 Generation of nucleotide sequence which can be used as tools of gene therapy; obtain cells, transform with expression vector, recover transformed cells, detect methyltransferase expression and methylated nucleotide sequences
12/12/2002US20020187525 Genetically engineered streptomyces for use in the generation of an enzymatic polypeptide for use in food processing or medicines
12/12/2002US20020187524 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferation, diabetic and psychological disorders
12/12/2002US20020187523 Extracellular signaling molecules
12/12/2002US20020187515 Composite arrays utilizing microspheres
12/12/2002US20020187509 Methods for detecting interaction between a test moiety and a plurality of target moieties
12/12/2002US20020187508 Analysis of preferential nucleotide sequences for use in human therapeutics; obtain nucleic acid sequences, incubate with cutting enzyme, expose to primers, amplify, evaluate for preferential genetic disorders
12/12/2002US20020187507 Polynucleotides related to pancreatic disease
12/12/2002US20020187503 Concentration and purification of analytes using electric fields
12/12/2002US20020187500 Labeling nucleotide sequences; obtain nucleotide sequences, incubate with primer, amplify, transcribe sequences, cleave sequences, incubate with label, recover labeled nucleotide sequences
12/12/2002US20020187499 Kit for use in monitoring and treatment of endometriosis
12/12/2002US20020187498 Screening modulators of skin allergies; obtain sample, incubate with modulator, monitor and evaluate response
12/12/2002US20020187497 Detection of preferential ribosome binding site in sample of nuceotide sequences; genetically engineered cell, incubate with substrate, detect signal from reporter molecule, presence of signal indicates preferential binding site
12/12/2002US20020187492 Nucleotide sequences coding polypeptides for use in the treatnment of inflammation
12/12/2002US20020187489 Method for screening for enzyme activity
12/12/2002US20020187486 Detection of preferential nucleotide sequences in sample; obtain target nucleic acid sample, incubate with nucleases, expose to probes, detect preferential nucleotide sequences
12/12/2002US20020187484 Molecular break lights probes for detecting nucleotide cleavage
12/12/2002US20020187482 Methods and means of RNA analysis
12/12/2002US20020187475 Amplification of preferential nucleotide sequences; obtain nucleotide sequence, incubate with primers, amplify, recover nucleotide sequence products
12/12/2002US20020187472 Nucleotide sequences coding protein for use in the treatment of cancer
12/12/2002US20020187471 Novel telomerase
12/12/2002US20020187466 Detection of infections in humans; obtain sample, incubate with antibody, detect signal, presence of signal indicates infection
12/12/2002US20020187464 Microarray-based method for rapid identification of cells, microorganisms, or protein mixtures
12/12/2002US20020187206 Method and apparatus for fractional separation of proteins from plant material
12/12/2002US20020187163 Herpes simplex virus comprising a mutation within the BstEII-EcoNI fragment of the BamHI x fragment of said virus; cancer vaccine
12/12/2002US20020187161 H. pylori antigens
12/12/2002US20020187160 Vaccine delivery system
12/12/2002US20020187157 Administering an amyloidogenic polypeptide or subsequence thereof to induces production of antibodies against the amyloidogenic polypeptide; treatment of Alzheimer's disease
12/12/2002US20020187143 Methods and compositions for reducing immune response
12/12/2002US20020187141 Composites that bind a multidrug transporter protein and an antigen associated with a tumor or infectious agent; determination whether the failure of traditional chemotherapy is due to multidrug resistant tumor cells
12/12/2002US20020187140 Two novel human cathepsin proteins
12/12/2002US20020187135 Methods for inducing antigen-specific t cell tolerance
12/12/2002US20020187132 Cardiac gene transfer
12/12/2002US20020187131 Conjugating an antigen to a molecule targeted to an endocytic receptor on the dendritic cell, such as DEC-205. The molecule targeted may be a natural ligand to the receptor or an antibody thereto.
12/12/2002US20020187129 Adeno-associated virus materials and methods
12/12/2002US20020187128 Novel replication deficient adenovirus vectors and methods for making and using them
12/12/2002US20020187127 Methods of increasing distribution of nucleic acids
12/12/2002US20020187125 Reovirus for the treatment of neoplasia
12/12/2002US20020185441 System and method for performing polynucleotide separations using liquid chromatography
12/12/2002DE10127882A1 Cassette for expressing transgene, useful e.g. in production of pharmaceuticals and fine chemicals, contains promoter from the LOX5 gene of Arabidopsis, provides cotyledon-specific expression
12/12/2002CA2830887A1 Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
12/12/2002CA2735990A1 Sequences for the detection and identification of methicillin-resistant staphylococcus aureus mrej type vii strains
12/12/2002CA2463310A1 Compositions and methods for high-level, large-scale production of recombinant proteins
12/12/2002CA2457959A1 Pharmaceutical composition containing a stabilised mrna optimised for translation in its coding regions
12/12/2002CA2452865A1 Conditioned cell culture media and uses thereof
12/12/2002CA2451765A1 Gene expression and production of tgf-b proteins including bioactive mullerian inhibiting substance from plants
12/12/2002CA2449940A1 Bcl-2 dnazymes
12/12/2002CA2449890A1 B7-related nucleic acids and polypeptides useful for immunomodulation
12/12/2002CA2449885A1 Improved isoprenoid production
12/12/2002CA2449837A1 Implantation of biological pacemaker that is molecularly determined
12/12/2002CA2449810A1 Anther-specific taa1 genes encoding fatty acyl co-a reductases, and uses thereof
12/12/2002CA2449752A1 Method of identifying a polymorphism in cyp2d6
12/12/2002CA2449708A1 A single-cell biosensor for the measurement of gpcr ligands in a test sample
12/12/2002CA2449670A1 Mutant forms of cholera holotoxin as an adjuvant
12/12/2002CA2449663A1 Mutant forms of cholera holotoxin as an adjuvant
12/12/2002CA2449658A1 Use of rank antagonists to treat cancer
12/12/2002CA2449647A1 Methods and compositions for assessment of pulmonary function and disorders
12/12/2002CA2449482A1 Chds as modifiers of the p53 pathway and methods of use
12/12/2002CA2449479A1 Map3ks as modifiers of the p53 pathway and methods of use
12/12/2002CA2449425A1 Slc2as as modifiers of the p53 pathway and methods of use
12/12/2002CA2449303A1 Method for targeting transcriptionally active loci
12/12/2002CA2449290A1 Mutants of igf binding proteins and methods of production of antagonists thereof
12/12/2002CA2449289A1 Gfats as modifiers of the p53 pathway and methods of use
12/12/2002CA2449281A1 Prmts as modifiers of the p53 pathway and methods of use
12/12/2002CA2449275A1 Dgks as modifiers of the p53 pathway and methods of use
12/12/2002CA2449273A1 Lipoxygenase overexpression in plants and reduction in plant sensitivity to diseases and attacks from pathogenic organisms
12/12/2002CA2449270A1 Pibs as modifiers of the p53 pathway and methods of use
12/12/2002CA2449267A1 Hs2sts as modifiers of the p53 pathway and methods of use
12/12/2002CA2449221A1 P5crs as modifiers of the p53 pathway and methods of use
12/12/2002CA2449206A1 Cads as modifiers of the p53 pathway and methods of use
12/12/2002CA2449136A1 Igs as modifiers of the p53 pathway and methods of use
12/12/2002CA2449135A1 Adsls as modifiers of the p53 pathway and methods of use
12/12/2002CA2449132A1 Recombinant antibodies against infectious bursal disease virus (ibdv)
12/12/2002CA2449008A1 Compositions and methods for systemic administration of sequences encoding bone morphogenetic proteins
12/12/2002CA2448881A1 Sugar and lipid metabolism regulators in plants ii
12/12/2002CA2448824A1 Novel compounds for chemiluminescense procedures
12/12/2002CA2448606A1 Nucleic acid-associated proteins
12/12/2002CA2448591A1 T cell induced tissue repair and regeneration
12/12/2002CA2448444A1 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
12/12/2002CA2448427A1 Molecules and methods for inhibiting shedding of kim-1
12/12/2002CA2448384A1 Transcriptional regulator of genes involved in the control of cell growth or cell proliferation. use of said regulator as a therapeutic or diagnostic agent
12/12/2002CA2448382A1 Use of hepcidin as a regulator of iron homeostasis
12/12/2002CA2448323A1 Tobacco biomass utilization
12/12/2002CA2448282A1 Slc7s as modifiers of the p53 pathway and methods of use
12/12/2002CA2448250A1 Limks as modifiers of the p53 pathway and methods of use
12/12/2002CA2448112A1 Lces as modifiers of the p53 pathway and methods of use
12/12/2002CA2448107A1 Marks as modifiers of the p53 pathway and methods of use
12/12/2002CA2448066A1 Chimeric alphavirus replicon particles
12/12/2002CA2447935A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
12/12/2002CA2447695A1 Modified antibodies to prostate-specific membrane antigen and uses thereof
12/12/2002CA2446211A1 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
12/12/2002CA2445748A1 Insecticidal proteins and synergistic combinations thereof
12/12/2002CA2445099A1 Method to measure gene expression ratio of key genes
12/12/2002CA2438571A1 Novel proteins and nucleic acids encoding same
12/12/2002CA2430697A1 Atp-binding cassette transporter-like molecules and uses thereof
12/12/2002CA2418088A1 Numb protein expression inhibitors by musashi 1
1 ... 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 2651 2652 2653 2654 2655 2656 2657 2658 2659 2660 ... 4023